Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.
about
Prevention and treatment of cryptosporidiosis in immunocompromised patientsPrevention and treatment of cryptosporidiosis in immunocompromised patientsDrug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and GiardiaA review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.Antibiotics for the treatment of Cholera, Shigella and Cryptosporidium in childrenThe evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalationNitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infectionsTreatment options for the eradication of intestinal protozoaNitazoxanide: a new broad spectrum antiparasitic agentChallenges in the Management of HIV-Infected Malnourished Children in Sub-Saharan AfricaThe ancillary-care obligations of medical researchers working in developing countries.Antimicrobial drugs for persistent diarrhoea of unknown or non-specific cause in children under six in low and middle income countries: systematic review of randomized controlled trialsHigh dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerIn a trial of the use of miltefosine to treat HIV-related cryptosporidiosis in Zambian adults, extreme metabolic disturbances contribute to high mortality.Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theCryptosporidium muris: infectivity and illness in healthy adult volunteers.Treatment of Cryptosporidium: What We Know, Gaps, and the Way ForwardSevere acute malnutrition and infection.Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds.Parasitic diarrhea in normal and malnourished children.Cases of cryptosporidiosis co-infections in AIDS patients: a correlation between clinical presentation and GP60 subgenotype lineages from aged formalin-fixed stool samples.Nitazoxanide treatment for giardiasis and cryptosporidiosis in children.Management of protozoa-related diarrhea in HIV infection.Integration of HIV Care into Community Management of Acute Childhood Malnutrition Permits Good Outcomes: Retrospective Analysis of Three Years of a Programme in Lusaka.Rapid displacement of Cryptosporidium parvum type 1 by type 2 in mixed infections in piglets.A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments.Treatment of cryptosporidiosis in immunocompromised hosts.Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysisAdvances in the epidemiology, diagnosis and treatment of cryptosporidiosis.Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients.Cryptosporidium parvum-specific CD4 Th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins.Wasting disease in African children: the challenges aheadTreatment of parasitic diarrhea in HIV-infected patients.Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge.Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.Cryptosporidium and Toxoplasma Parasites Are Inhibited by a Benzoxaborole Targeting Leucyl-tRNA Synthetase.
P2860
Q24246356-55FDFEA5-3F0E-4695-951E-18D912E37036Q24247353-F2BF3237-3E9C-4B7D-8532-E053CF3D8CE9Q26774724-A4D8D8C2-9015-43A6-B8BB-7A3B16826600Q26851900-B37CAC2B-2188-4312-AF4D-0FB9AD543862Q27009922-982DAEC2-57A9-46E1-A89A-20B6FA02D0B8Q27027858-2BDA18C0-A288-496E-9BEE-16F5A2F4E494Q28236279-46151342-ABAE-4CE5-8E6B-FC35B9B66029Q28255378-9FF77B60-3E79-4EFF-AABE-601D44485534Q28287647-E2CC2F39-3254-491B-8ED8-4151111F7680Q28729942-7D0DC86E-DF1F-4782-ACAF-C2B977C74643Q33336755-71E46DA1-2147-414C-800F-D78ABBCC2B55Q33414405-7B4C070A-DE57-4DC6-ABDA-15AA1DAF5E50Q33517055-4662AAE6-6BD7-477C-81A6-EA32F066F9BBQ33650105-5F0859D6-44A9-449F-A7A1-F94FA7E4CBA0Q33854925-C99EFB94-93BF-4D21-802B-A0F8641E6BB6Q34169216-8D753170-AD92-4893-845B-9BC28EF8CB92Q34212799-C392A967-DF54-49F4-8411-40C23B44C399Q34443371-3BAB71F8-8C94-4E76-87C4-221027C3DF6AQ34501816-00260023-C285-45AF-B0DE-0345372A1A3BQ34701568-DE463D26-A7CF-434B-85AE-4BB1E73CE3E3Q34767710-41C696E7-B94E-49EE-99A3-2C542FF41132Q35095255-C2A3CE68-A86D-4423-8506-AABD295ABCBBQ35222537-7948A172-5DEC-4580-9F65-1E210699EC80Q35678259-674AEB58-2810-47D5-AFDE-F02D9F37327CQ35917249-C24221CE-E099-42B8-8140-8645CD7B1847Q35946052-A64C45D1-6587-4224-83E4-575006729DF8Q36046487-3AA21349-B7EB-409C-8A37-4CAC8C894655Q36137064-3893711B-164D-471E-82DC-809D21B5BBBAQ36188559-C0A0E702-AF7E-44F6-AF4E-939531533EDAQ36268294-9E0FA670-FB99-48C0-8F6A-17C845BAD63AQ36386240-C9DE9F89-7200-4839-B912-B4FB0D2F1D66Q36388002-3A347C27-D951-4A22-B991-C6A7F12A5692Q36505502-E7F95873-2DF1-4BF9-A31B-ACCB09E9154CQ36570821-B9F27A9D-65A9-4E07-8C43-4998F756C249Q36576157-A1D4DF42-1F32-4F18-AFCB-70CFD50D0E0BQ37030050-8A8CD8F0-DE9B-49AE-9444-8ACE93395070Q37202848-1CA8B472-CCE2-4866-A32B-21468C89DF7DQ37247787-5AE6F4DA-51A7-4FA8-BB80-9822D45E34D4Q37277077-D7E287F2-B439-44D7-9C0C-15DA6344B38BQ37287878-E53FA37D-6F3A-4157-B99F-3EDEE8E27D11
P2860
Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effect of nitazoxanide on morb ...... a randomised controlled trial.
@en
Effect of nitazoxanide on morb ...... a randomised controlled trial.
@nl
type
label
Effect of nitazoxanide on morb ...... a randomised controlled trial.
@en
Effect of nitazoxanide on morb ...... a randomised controlled trial.
@nl
prefLabel
Effect of nitazoxanide on morb ...... a randomised controlled trial.
@en
Effect of nitazoxanide on morb ...... a randomised controlled trial.
@nl
P2093
P1433
P1476
Effect of nitazoxanide on morb ...... a randomised controlled trial.
@en
P2093
Angela Watuka
Ayman Ayoub
Beatrice Amadi
John Musuku
Mwiya Mwiya
Paul Kelly
Sandie Sianongo
P304
P356
10.1016/S0140-6736(02)11401-2
P407
P577
2002-11-01T00:00:00Z